mAb-13G8

N/A

Report date: 2024/10/08 09:47:50

Base Information

Drug NamemAb-13G8
Drug Alias NamemAb-9D5
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionNucleocapsid proteins inhibitors
TargetsNucleocapsid proteins
Therapy Area/IndicationsHemorrhagic Fever, Crimean
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Georgia
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Georgia
Inactive CompaniesN/A
Active IndicationsHemorrhagic Fever, Crimean
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A